view counter
view counter

Notices Regarding Levamisole, EIPH

October 30, 2018:

On Tuesday (Oct. 30), the Canadian Pari-Mutuel Agency issued a pair of notices, one in regard to the use of Levamisole and the other in regard to provincial Exercise-Induced Pulmonary Hemorrhage on

CPMA Clarification On EIPH List

October 30, 2018:

The Canadian Pari-Mutuel Agency (CPMA) has received an inquiry concerning the requirement for a horse to remain on a provincial Exercise-Induced Pulmonary Hemorrhage (EIPH) list for 100 days, when the horse moves from one EIPH list to a new province’s EIPH on

New Rules Proposed After Investigation

November 23, 2015:

On Monday, November 23, the New York State Gaming Commission announced it will pursue 'sweeping' equine drug medication regulations in the wake of its investigation into allegations against the practices of Thoroughbred trainer Steve Asmussen, assistant Scott Blasi and others during the 2013 Saratoga Race Course on

US HBPA: Don't Ban Lasix

July 25, 2011:

Due to its effectiveness in treating Exercise-Induced Pulmonary Hemorrhage, the National Horsemen’s Benevolent and Protective Association in the United States has announced that it is against a race-day ban on lasix, which bucks current industry on

Study: Furosemide Reduces EIPH

June 29, 2009:

According to the results of a recent study, it has been proven that furosemide decreases the incidence of exercise-induced pulmonary hemorrhage (EIPH) in racehorses.

The study, conducted by Colorado State University, the University of Melbourne and the University of Pretoria in the Republic of South Africa, revolved around 167 thoroughbred on

view counter

© 2021 Standardbred Canada. All rights reserved. Use of this site signifies your agreement and compliance with the legal disclaimer and privacy policy.

Firefox 3 Best with IE 7 Built with Drupal